187 related articles for article (PubMed ID: 21856745)
1. miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer.
Nishikawa E; Osada H; Okazaki Y; Arima C; Tomida S; Tatematsu Y; Taguchi A; Shimada Y; Yanagisawa K; Yatabe Y; Toyokuni S; Sekido Y; Takahashi T
Cancer Res; 2011 Oct; 71(19):6165-73. PubMed ID: 21856745
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.
Xiao L; Zhou H; Li XP; Chen J; Fang C; Mao CX; Cui JJ; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2016 Jun; 7(26):40038-40046. PubMed ID: 27223073
[TBL] [Abstract][Full Text] [Related]
3. A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop.
Wu DW; Wang YC; Wang L; Chen CY; Lee H
Theranostics; 2018; 8(5):1256-1269. PubMed ID: 29507618
[No Abstract] [Full Text] [Related]
4. Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer.
Osada H; Tomida S; Yatabe Y; Tatematsu Y; Takeuchi T; Murakami H; Kondo Y; Sekido Y; Takahashi T
Cancer Res; 2008 Mar; 68(6):1647-55. PubMed ID: 18339843
[TBL] [Abstract][Full Text] [Related]
5. Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma.
Enokido T; Horie M; Yoshino S; Suzuki HI; Matsuki R; Brunnström H; Micke P; Nagase T; Saito A; Miyashita N
Mol Cancer Res; 2024 Jan; 22(1):29-40. PubMed ID: 37801008
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells.
Dang X; Ma A; Yang L; Hu H; Zhu B; Shang D; Chen T; Luo Y
Cancer Genet; 2012 Mar; 205(3):113-23. PubMed ID: 22469510
[TBL] [Abstract][Full Text] [Related]
7. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
8. Loss of MiR-424-3p, not miR-424-5p, confers chemoresistance through targeting YAP1 in non-small cell lung cancer.
Zhang M; Zeng J; Zhao Z; Liu Z
Mol Carcinog; 2017 Mar; 56(3):821-832. PubMed ID: 27500472
[TBL] [Abstract][Full Text] [Related]
9. ASH1 gene is a specific therapeutic target for lung cancers with neuroendocrine features.
Osada H; Tatematsu Y; Yatabe Y; Horio Y; Takahashi T
Cancer Res; 2005 Dec; 65(23):10680-5. PubMed ID: 16322211
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1.
Zhang MY; Lin J; Kui YC
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2436-2443. PubMed ID: 30964169
[TBL] [Abstract][Full Text] [Related]
11. MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer.
Ou C; Sun Z; Li X; Li X; Ren W; Qin Z; Zhang X; Yuan W; Wang J; Yu W; Zhang S; Peng Q; Yan Q; Xiong W; Li G; Ma J
Cancer Lett; 2017 Jul; 399():53-63. PubMed ID: 28433598
[TBL] [Abstract][Full Text] [Related]
12. Insights into the achaete-scute homolog-1 gene (hASH1) in normal and neoplastic human lung.
Miki M; Ball DW; Linnoila RI
Lung Cancer; 2012 Jan; 75(1):58-65. PubMed ID: 21684625
[TBL] [Abstract][Full Text] [Related]
13. Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma.
Kang W; Tong JH; Lung RW; Dong Y; Zhao J; Liang Q; Zhang L; Pan Y; Yang W; Pang JC; Cheng AS; Yu J; To KF
Mol Cancer; 2015 Feb; 14():52. PubMed ID: 25743273
[TBL] [Abstract][Full Text] [Related]
14. ASCL1-coexpression profiling but not single gene expression profiling defines lung adenocarcinomas of neuroendocrine nature with poor prognosis.
Fujiwara T; Hiramatsu M; Isagawa T; Ninomiya H; Inamura K; Ishikawa S; Ushijima M; Matsuura M; Jones MH; Shimane M; Nomura H; Ishikawa Y; Aburatani H
Lung Cancer; 2012 Jan; 75(1):119-25. PubMed ID: 21737174
[TBL] [Abstract][Full Text] [Related]
15. COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells.
Pu X; Wang J; Li W; Fan W; Wang L; Mao Y; Yang S; Liu S; Xu J; Lv Z; Xu L; Shu Y
Biomed Pharmacother; 2018 Jul; 103():373-380. PubMed ID: 29674272
[TBL] [Abstract][Full Text] [Related]
16. MiR-497 Suppresses YAP1 and Inhibits Tumor Growth in Non-Small Cell Lung Cancer.
Huang C; Ma R; Yue J; Li N; Li Z; Qi D
Cell Physiol Biochem; 2015; 37(1):342-52. PubMed ID: 26316081
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-16 inhibits the proliferation and metastasis of human lung cancer cells by modulating the expression of YAP1.
Wei J; Jia A; Ma L; Wang Y; Qiu L; Xiao B
J BUON; 2020; 25(2):862-868. PubMed ID: 32521879
[TBL] [Abstract][Full Text] [Related]
18. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
[TBL] [Abstract][Full Text] [Related]
19. miR-138 suppresses the proliferation of oral squamous cell carcinoma cells by targeting Yes-associated protein 1.
Xu R; Zeng G; Gao J; Ren Y; Zhang Z; Zhang Q; Zhao J; Tao H; Li D
Oncol Rep; 2015 Oct; 34(4):2171-8. PubMed ID: 26239136
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1.
Deng J; Lei W; Xiang X; Zhang L; Yu F; Chen J; Feng M; Xiong J
Tumour Biol; 2015 Sep; 36(9):6823-31. PubMed ID: 25846731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
